cytarabine has been researched along with sgi 1776 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atallah, G; Aycinena, A; Basham, S; Bellamacina, C; Burger, MT; Castillo, J; Chan, J; Chen, MY; Dai, Y; Ding, Y; Feucht, P; Fritsch, C; Garcia, PD; Ginn, E; Han, W; Holash, J; Huh, K; Kauffmann, A; Lambert, A; Lan, J; Langowski, JL; Lindvall, MK; Mathur, M; Muller, K; Nishiguchi, G; Pfister, E; Simmons, R; Tamez, V; Vanasse, KG; Wang, Y; Zang, R; Zavorotinskaya, T; Zhang, Y | 1 |
| Carew, JS; Choy, G; Espitia, CM; Giles, FJ; Kelly, KR; Nawrocki, ST; Padmanabhan, S; Taverna, P | 1 |
2 other study(ies) available for cytarabine and sgi 1776
| Article | Year |
|---|---|
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Tria
Topics: Amides; Animals; Cell Line, Tumor; Halogenation; Humans; Leukemia, Myeloid, Acute; Mice; Models, Molecular; Picolinic Acids; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-pim-1 | 2015 |
Targeting PIM kinase activity significantly augments the efficacy of cytarabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cytarabine; Drug Synergism; Humans; Imidazoles; Leukemia, Myeloid, Acute; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyridazines | 2012 |